These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 4846267)

  • 41. [The platelet model applied to the study of depressive illness (author's transl)].
    Dreux C; Launay JM; Giret M
    Ann Biol Clin (Paris); 1979; 37(1):41-7. PubMed ID: 443612
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A comparison of nortriptyline and amitriptyline in depression.
    Rose JT; Leahy MR; Martin IC; Westhead TT
    Br J Psychiatry; 1965 Nov; 111(480):1101-3. PubMed ID: 5841221
    [No Abstract]   [Full Text] [Related]  

  • 43. [Clinical studies of a new antidepressive agent, nortriptyline].
    Ropert R; Sivadon P
    Ann Med Psychol (Paris); 1967 May; 125(5):744-50. PubMed ID: 6064542
    [No Abstract]   [Full Text] [Related]  

  • 44. [Recent knowledge on the biochemical effects of antidepressive agents].
    Rysánek K
    Act Nerv Super (Praha); 1968 Feb; 10(1):85-93. PubMed ID: 4882492
    [No Abstract]   [Full Text] [Related]  

  • 45. Biochemistry and drug treatment of depression.
    Lancet; 1972 May; 1(7758):1001-2. PubMed ID: 4112322
    [No Abstract]   [Full Text] [Related]  

  • 46. CSF monoamine metabolites during treatment with mianserin or amitryptyline.
    Mendlewicz J; Pinder RM; Stulemeijer SM; van Dorth R
    Adv Biochem Psychopharmacol; 1982; 32():249-56. PubMed ID: 6178263
    [No Abstract]   [Full Text] [Related]  

  • 47. [THE BIOGENIC AMINES AND ANTIDEPRESSIVE EFFECT].
    PLETSCHER A
    Arzneimittelforschung; 1964 Jun; 14():SUPPL:479-82. PubMed ID: 14253942
    [No Abstract]   [Full Text] [Related]  

  • 48. [Depressive syndromes. Evaluation of results in the use of various thymoanaleptics].
    de Paiva LM
    Hospital (Rio J); 1968 May; 73(5):1575-83. PubMed ID: 5308757
    [No Abstract]   [Full Text] [Related]  

  • 49. Inhibition of 5-hydroxytryptamine reuptake by amitryptyline an zimelidine and its relationship to their therapeutic action.
    Coppen A; Rama Rao VA; Swade C; Wood K
    Psychopharmacology (Berl); 1979 May; 63(2):125-9. PubMed ID: 112630
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical studies with MO-1255, a new monoamine oxidase inhibitor antidepressant.
    Ban TA; St-Jean A; Lehmann HE
    Curr Ther Res Clin Exp; 1966 Dec; 8(12):614-6. PubMed ID: 4962732
    [No Abstract]   [Full Text] [Related]  

  • 51. [Antidepressive drugs and their clinical use].
    Meoni GC
    Clin Ter; 1972 Jun; 61(6):545-72. PubMed ID: 4592993
    [No Abstract]   [Full Text] [Related]  

  • 52. Clomipramine and amitriptyline in depressed outpatients. A controlled study.
    Rickels K; Weise CC; Csanalosi I; Chung HR; Feldman HS; Rosenfeld H; Whalen EM
    Psychopharmacologia; 1974 Feb; 34(4):361-76. PubMed ID: 4812659
    [No Abstract]   [Full Text] [Related]  

  • 53. The inhibition of the uptake of monoamines by blood platelets by phenothiazines and other drugs.
    Ahtee L; Boullin DJ; Saarnivaara L; Paasonen MK
    Adv Biochem Psychopharmacol; 1974; 9(0):379-88. PubMed ID: 4836214
    [No Abstract]   [Full Text] [Related]  

  • 54. The biochemistry of therapy-resistant depression. Contributions to biochemistry.
    Coppen A
    Pharmakopsychiatr Neuropsychopharmakol; 1974 Mar; 7(2):85-7. PubMed ID: 4438428
    [No Abstract]   [Full Text] [Related]  

  • 55. Resiliency of monoaminergic systems: the 80% rule and its relevance to drug development.
    Blier P
    J Psychopharmacol; 2008 Aug; 22(6):587-9. PubMed ID: 18753271
    [No Abstract]   [Full Text] [Related]  

  • 56. A choice--drugs or electroshock for depression.
    Koutsky CD
    Dis Nerv Syst; 1966 Dec; 27(12):806-7. PubMed ID: 5954741
    [No Abstract]   [Full Text] [Related]  

  • 57. Antidepressants.
    Rossi GV
    Am J Pharm Sci Support Public Health; 1968; 140(3):75-82. PubMed ID: 5661866
    [No Abstract]   [Full Text] [Related]  

  • 58. Clinical and biochemical aspects of depression.
    Dunlop E
    Psychosomatics; 1970; 11(5):422-5. PubMed ID: 5470666
    [No Abstract]   [Full Text] [Related]  

  • 59. Reversible monoamine oxidase-A inhibitors in resistant major depression.
    Nolen WA; Hoencamp E; Bouvy PF; Haffmans PM
    Clin Neuropharmacol; 1993; 16 Suppl 2():S69-76. PubMed ID: 8313400
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Some current aspects of antidepressive therapy].
    Predescu V; Vianu I
    Neurol Psihiatr Neurochir; 1967; 12(6):485-94. PubMed ID: 5593224
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.